X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3438) 3438
leupeptins - pharmacology (3341) 3341
animals (2100) 2100
humans (1899) 1899
cysteine proteinase inhibitors - pharmacology (1101) 1101
biochemistry & molecular biology (931) 931
rats (788) 788
mice (736) 736
cell biology (721) 721
proteasome endopeptidase complex - metabolism (662) 662
cell line (635) 635
proteasome inhibitors (594) 594
cells, cultured (564) 564
male (563) 563
proteasome endopeptidase complex (464) 464
apoptosis (459) 459
cell line, tumor (435) 435
proteins (430) 430
degradation (428) 428
protease inhibitors - pharmacology (427) 427
expression (387) 387
proteasome (369) 369
phosphorylation (368) 368
apoptosis - drug effects (351) 351
oligopeptides - pharmacology (350) 350
activation (345) 345
female (341) 341
ubiquitin (325) 325
cysteine endopeptidases - metabolism (323) 323
time factors (308) 308
transfection (303) 303
oncology (295) 295
blotting, western (281) 281
multienzyme complexes - metabolism (281) 281
cells (278) 278
kinetics (277) 277
ubiquitin - metabolism (277) 277
dose-response relationship, drug (270) 270
enzyme inhibitors - pharmacology (257) 257
proteolysis (254) 254
acetylcysteine - pharmacology (244) 244
tumor cells, cultured (233) 233
nf-kappa b - metabolism (230) 230
acetylcysteine - analogs & derivatives (224) 224
neurosciences (216) 216
protein (214) 214
mutation (211) 211
pathway (208) 208
hela cells (207) 207
rna, messenger - metabolism (205) 205
signal transduction (205) 205
molecular sequence data (203) 203
amino acid sequence (202) 202
antineoplastic agents - pharmacology (188) 188
ubiquitination (188) 188
inhibition (187) 187
research (187) 187
leupeptin (185) 185
multienzyme complexes - antagonists & inhibitors (185) 185
proteasome inhibitors - pharmacology (182) 182
protein binding (182) 182
cancer (181) 181
oxidative stress (181) 181
biophysics (174) 174
lysosomes - metabolism (170) 170
nf-kappa-b (168) 168
in vitro techniques (166) 166
signal transduction - drug effects (165) 165
dna-binding proteins - metabolism (164) 164
gene expression (164) 164
article (163) 163
pharmacology & pharmacy (159) 159
cell survival - drug effects (158) 158
down-regulation (153) 153
rats, sprague-dawley (152) 152
cell nucleus - metabolism (151) 151
calpain - antagonists & inhibitors (150) 150
gene-expression (148) 148
multidisciplinary sciences (147) 147
physiological aspects (144) 144
analysis (142) 142
immunology (141) 141
mg132 (141) 141
chloroquine - pharmacology (140) 140
ubiquitins - metabolism (137) 137
cycloheximide - pharmacology (135) 135
liver - metabolism (134) 134
abridged index medicus (133) 133
transcription factors - metabolism (132) 132
in-vivo (130) 130
protease inhibitors (129) 129
rats, inbred strains (129) 129
autophagy (127) 127
rna, messenger - genetics (125) 125
cell proliferation - drug effects (124) 124
in-vitro (124) 124
cysteine endopeptidases (123) 123
research article (123) 123
endoplasmic-reticulum (122) 122
gene expression regulation - drug effects (122) 122
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 08/2012, Volume 32, Issue 33, pp. 11356 - 11364
Journal Article
Journal of Inorganic Biochemistry, ISSN 0162-0134, 12/2015, Volume 153, pp. 49 - 59
Heart tissue becomes zinc-depleted and the capacity to mobilize labile zinc is diminished, indicating zinc dyshomeostasis during ischemia/reperfusion (I/R).... 
Hypoxia | Reoxygenation | Proteolysis | Caspase-3 | Zinc | Apoptosis | ACTIVATION | RAT | MITOCHONDRIAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | REPERFUSION INJURY | CARDIOMYOPATHY | CARDIAC-CELLS | DEATH | INTRACELLULAR ZINC | CHEMISTRY, INORGANIC & NUCLEAR | ACUTE MYOCARDIAL-INFARCTION | Receptor, Epidermal Growth Factor - genetics | Caspase Inhibitors - pharmacology | Phosphorylation | Receptor, ErbB-2 - genetics | Protein Multimerization | Caspase 3 - metabolism | Receptor, ErbB-2 - metabolism | RNA, Messenger - metabolism | Cell Hypoxia | Receptor, Epidermal Growth Factor - metabolism | Zinc Compounds - pharmacology | Amino Acid Chloromethyl Ketones - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Benzothiazoles - pharmacology | Chlorides - pharmacology | Down-Regulation | RNA, Messenger - genetics | Rats | Tyrphostins - pharmacology | Cardiotonic Agents - pharmacology | Leupeptins - pharmacology | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Thiones - pharmacology | Quinazolines - pharmacology | Organometallic Compounds - pharmacology | Proteins | Membrane lipids | Inositol | RNA | Antifungal agents | Permeability | Antibacterial agents | Phosphotransferases | Tyrosine | Cell death | Index Medicus
Journal Article
Apoptosis, ISSN 1360-8185, 4/2013, Volume 18, Issue 4, pp. 393 - 408
Journal Article
Neuron, ISSN 0896-6273, 2006, Volume 51, Issue 4, pp. 441 - 454
Genetic deletion of fragile X mental retardation protein (FMRP) has been shown to enhance mGluR-dependent long-term depression (LTD). Herein, we demonstrate... 
HUMDISEASE | MOLNEURO | SYSTEM | MESSENGER-RNAS | SYNAPSES | UBIQUITIN | FMR1 | MOUSE MODEL | DEGRADATION | GLUTAMATE-RECEPTOR ACTIVATION | HIPPOCAMPAL AREA CA1 | SYNAPTIC PLASTICITY | NEUROSCIENCES | Glycine - analogs & derivatives | Microtubule-Associated Proteins - metabolism | Protein Biosynthesis - physiology | Receptors, Metabotropic Glutamate - physiology | Male | Fragile X Mental Retardation Protein - metabolism | Long-Term Synaptic Depression - drug effects | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Drug Interactions | Protein Synthesis Inhibitors - pharmacology | Animals, Newborn | Long-Term Synaptic Depression - physiology | Blotting, Western - methods | Fluorescent Antibody Technique - methods | Excitatory Amino Acid Antagonists - pharmacology | Mice, Knockout | Leupeptins - pharmacology | Methoxyhydroxyphenylglycol - analogs & derivatives | Methoxyhydroxyphenylglycol - pharmacology | Animals | Glycine - pharmacology | Signal Transduction - drug effects | Models, Biological | Cysteine Proteinase Inhibitors - pharmacology | Benzoates - pharmacology | Anisomycin - pharmacology | Protein Biosynthesis - drug effects | Fragile X Mental Retardation Protein - genetics | Mice | Pyridines - pharmacology | Proteasome Endopeptidase Complex - metabolism | In Vitro Techniques | Ubiquitin | Physiological aspects | Neurosciences | Proteolysis | Mental retardation | Depression, Mental | Proteins | Studies | Software | Protein synthesis | Experiments | Index Medicus
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2013, Volume 33, Issue 3, pp. 595 - 604
Journal Article
Nature Cell Biology, ISSN 1465-7392, 10/2011, Volume 13, Issue 10, pp. 1265 - 1271
Journal Article
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 2014, Volume 350, Issue 1, pp. 89 - 98
Journal Article
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 2014, Volume 34, Issue 18, pp. 3435 - 3449
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 02/2008, Volume 19, Issue 2, pp. 115 - 124
Journal Article
Nature Neuroscience, ISSN 1097-6256, 10/2011, Volume 14, Issue 10, pp. 1293 - 1301
Oligophrenin-1 regulates dendritic spine morphology in the brain. Mutations in the oligophrenin-1 gene (OPHN1) cause intellectual disability. We discovered a... 
RESPONSE ELEMENT | INTELLECTUAL DISABILITY | LINKED MENTAL-RETARDATION | SUPRACHIASMATIC NUCLEUS | KAINIC ACID NEUROTOXICITY | GENE-EXPRESSION | ORPHAN RECEPTOR | PROTEIN OLIGOPHRENIN-1 | VENTRICULAR ENLARGEMENT | NEUROSCIENCES | CEREBELLAR HYPOPLASIA | Cytoskeletal Proteins - genetics | Embryo, Mammalian | Humans | Circadian Clocks - genetics | Green Fluorescent Proteins - genetics | RNA, Messenger - metabolism | Drug Interactions | Time Factors | Nuclear Proteins - deficiency | Tetrodotoxin - pharmacology | GABA-A Receptor Antagonists - pharmacology | Rats | Excitatory Amino Acid Antagonists - pharmacology | Bicuculline - pharmacology | Mutation - genetics | Mice, Knockout | Leupeptins - pharmacology | Analysis of Variance | Cysteine Proteinase Inhibitors - pharmacology | Mice | GTPase-Activating Proteins - genetics | Circadian Clocks - physiology | GTPase-Activating Proteins - deficiency | Immunoprecipitation | Cercopithecus aethiops | Neurons - cytology | GTPase-Activating Proteins - metabolism | Cerebral Cortex - cytology | Cytoskeletal Proteins - deficiency | Quinoxalines - pharmacology | Transfection - methods | Neurons - physiology | Cytoskeletal Proteins - metabolism | Neurons - drug effects | Nuclear Proteins - genetics | Nuclear Receptor Subfamily 1, Group D, Member 1 - metabolism | Dendrites - metabolism | ARNTL Transcription Factors - genetics | Nuclear Receptor Subfamily 1, Group D, Member 1 - genetics | Gene Expression Regulation - genetics | RNA, Small Interfering - pharmacology | Valine - analogs & derivatives | Cells, Cultured | ARNTL Transcription Factors - metabolism | Nuclear Proteins - metabolism | Sodium Channel Blockers - pharmacology | Hippocampus - cytology | Two-Hybrid System Techniques | Animals | Valine - pharmacology | Index Medicus | Life Sciences | Neurons and Cognition
Journal Article